Phase 3 Haemodialysis Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Not Yet Recruiting
Phase 3
Colchicine for coronary protection on dialysis (CCPD)
Chronic Kidney DiseaseCardiovascular DiseaseHaemodialysis
Sydney Local Health District20 enrolled1 locationACTRN12625001063404
Completed
Phase 3
The Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study
end-stage kidney disease
haemodialysis
peritoneal dialysis
Australasian Kidney Trials Network- University of Queensland150 enrolled10 locationsACTRN12609000174280
Completed
Phase 3Phase 4
A placebo-controlled trial to assess the effect of aspirin and fish oil (omega-3 fatty acids) in the prevention of early thrombosis in arterio-venous fistulae in patients with chronic kidney disease requiring haemodialysis
Early thrombosis in arterio-venous fistulae in patients with Stage IV or V chronic kidney disease requiring haemodialysis
Australasian Kidney Trials Network950 enrolled26 locationsACTRN12607000569404